Home > Professional Team

Ching Tan is the managing partner and the chairman of investment committee of CD Capital, a private equity firm managing serveral USD and RMB healthcare funds. He has over 30 years' experience in healthcare and investment industries. He worked as a Vice President and General Manager of GE Healthcare in China and was responsible for CT,MR,digital X-ray,nuclearmedicine,molecular imaging and cardiovascular imaging products, etc. He also acquired extensive investment experience when he was working at Siguler Guff, Asia Tech VC and Booz&Company(Chicago). Ching holds an M.S.E degree in Biomedical Enigineering from Johns Hopkins University, and an M.B.A with honors from Univerisity of Chicago.

Larissa has 20+ years experience in management in healthcare industry. Prior to joining CD Capital, she was General Manager of Health Science at UL China.  She also held several leadership positions at J&J Medical and GE Healthcare China. Larissa received her B.S. from Tongji University and attained GE Certified six sigma black belt and  Diploma in management  from CEIBS.

Ruilin has 20+ years experience in management in healthcare industry. Prior to joining CD Capital, Ruilin was the Vice President and General Manager of Commercial Operations for Greater China at Illumina.  He also held several leadership positions at Thermo Fisher, including China head of Corporate Marketing and Commercial Operations. Prior to Thermo Fisher, Ruilin held roles as Vice President of Finance at OrbusNeich and Vice President of Business Development at Microport Medical (Group) Co.
Ruilin received his doctorate in medical engineering and medical physics from the Harvard-MIT Division of Health Sciences and Technology, a Masters of Business Administration from the Wharton School at the University of Pennsylvania, a master's in electrical engineering and computer science from Massachusetts Institute of Technology, and a bachelor's in biomedical engineering from Xi'an Jiaotong University.

Zhiguang is the managing director at CD Capital and joined the firm in 2014. Prior to joining CD Capital, he was an Associate at Guangzhou Yuexiu Fund and led many successful investments, such as CapitalBio Corporation,Osmunda and so on. After joining CD Capital, he led investments in Bioscience, Biohit and Matridx.

He received his B.S. from Peking University and M.S. from Hong Kong University.

Tianji is the managing director at CD Capital.  Prior to joining CD Capital, he was a Consultant at Accenture. Beside that, he had his own entrepreneurial experience and hence had profound knowledge on products,business model and operation skills for start-ups. After joining CD Capital, he led investments in Fussen,Smartee,MasterVision,Genecast,Soonsolid and Huigene.   

He received his B.A. from Fudan University and M.A. from University of St Andrews.

Chloe has 10+ years experience in fund management and investment. Prior to joining CD Capital, she was a Senior Investment Manager at Gopher Asset  Management and Senior Product Manager at Noah Private Wealth Management (NYSE:NOAH). Chloe received her B.A. from Fudan University and attained her MBA from CEIBS.

Ji has 5 years experience in investment and research in healthcare industry. Prior to joining CD Capital , he was an Investment Manager at GIG. He also had been responsible for patent research and project management at Shanghai Institute of Meteria Medica, Chinese Academy of Science. Ji received his B.S.  from Xi'an Jiaotong University and attained his M.S. from Shanghai Institute of Meteria Medica.

Guanhua has 8 years experience in investment and research in healthcare industry. Prior to joining CD Capital , he was an Investment Manager at CASSATR. He also had been responsible for Ultrasound and MR device development at GE and Mindray. Guanhua received his B.S.  and M.S. from Xi'an Jiaotong University.

Yiyuan has 2 years experience in healthcare research and investment. Prior to joining CD Capital, he was a research fellow at Institute of Pasteur of Shanghai, Chinese Academy of Sciences.He received his PH.D from Chinese Academy of Sciences and Bacholer's degree from Zhejiang University.

Dr. Hai is currently an associate at CD Capital. Prior to joining CD Capital, he is a strategy consultant in healthcare and high tech at Accenture Strategy. Dr. Hai holds a bachelor degree from Shanghai Jiao Tong University and a PhD from Washington University in St. Louis and Caltech, both in Biomedical Engineering.

Yiran Cui is the Investment Manager at CDCapital. She came to the current role from IQVIA, where she worked inManagement Consulting Department on strategic planning for innovative medicaldevices and IVD products. Yiran graduated with her Bachelor’s degree from ZhejiangUniversity, later got a Master’s degree of Biomedical Engineering fromMelbourne University.

Prior to joining CD Capital,Chang was a researcher with GE Healthcare China. Chang has her  Master's Degree in Biomedical Engineering from Tsinghua University.

2014 © CDBI Partners. All Rights Reserved. 沪ICP备15038150号